Systematic Review of Chloroprene: Studies Published Since the 2010 IRIS Assessment to Support Consideration of the Denka Request for Correction (RfC)

IRIS

Chloroprene

CASRN 126-99-8 | DTXSID5020316

Toxicological Review (PDF) (303 pp, 4.4 MB)
IRIS Summary (PDF) (30 pp, 299.8 KB)
Systematic Review of Chloroprene (Jan 2018)

On this page:

Overview
Background
Downloads

Overview

This document was developed in support of EPA's response to Request for Correction (RFC) #17002: Integrated Risk Information System; Toxicological Review of Chloroprene. The document describes the IRIS Program's evaluation of the literature published after the 2010 finalization of the IRIS Assessment of Chloroprene. This document includes EPA's Response (Attachment 1) and Systematic Review of Chloroprene Studies Public Since 2010 IRIS Assessment to Support Consideration of the Denka Request for Correction (RFC) (Attachment 2).

Note: Both attachments are provided from the single link listed in the downloads.

Top of Page

Background

Chloroprene (C4H5Cl) is a volatile, flammable liquid used primarily in the manufacture of polychloroprene or neoprene rubber. The latter is used to make diverse products, such as tires, wire coatings, and tubing. Human health risk concerns for chloroprene are primarily related to exposures via effluent and emissions from facilities that use chloroprene to produce polychloroprene elastomers or transport the product, although these exposure concerns have not been well characterized.

History/Chronology

Date	Description
07- Sep 2010	EPA released the final IRIS Toxicological Report and Summary for Chloroprene with the interagency science discussion draft with comments.
08- Jan	In support of Request for Correction (RFC) #17002, EPA released the following document which includes EPA's Response (Attachment 1) and Systematic Review of Chloroprene Studies Public Since 2010 IRIS Assessment to Support Consideration of the Denka Request for Correction (RFC) (Attachment 2).

Top of Page

Download(s)

Systematic Review of Chloroprene [CASRN 126-99-8] Studies Published Since 2010 IRIS Assessment to Support Consideration of the Denka Request for Correction (RFC)

If you have a disability and the format of any material on our web pages interferes with your ability to access the information, please reach out to us using the Contact Us about IRIS form for assistance. To enable us to respond in a manner most helpful to you, please indicate the nature of the accessibility problem, the web address of the requested material, your preferred format in which you want to receive the material (electronic format (ASCII, etc.), standard print, large print, etc.), and your contact information.